Exact Mass: 614.4185

Synaptolepis factor K1

C36H54O8 (614.3818)

CHAPS

C32H58N2O7S (614.3965)

D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents

Antibiotic X 14889C

C33H58O10 (614.403)

Ruminant feed additive. Ruminant feed additive

(6S,3'S,5'R,6'R)-6,3',5'-Trihydroxy-4,5,6',7'-tetradehydro-7,8,5',6'-tetrahydro-beta,beta-carotene-3,8-dione

C40H54O5 (614.3971)

Chaps

C32H58N2O7S (614.3965)

DG(13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

C38H62O6 (614.4546)

DG(13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/13:0/0:0)

C38H62O6 (614.4546)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C38H62O6 (614.4546)

DG(13:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/13:0)

C38H62O6 (614.4546)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

C38H62O6 (614.4546)

DG(13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/13:0/0:0)

C38H62O6 (614.4546)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C38H62O6 (614.4546)

DG(13:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/13:0)

C38H62O6 (614.4546)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

C38H62O6 (614.4546)

DG(13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/13:0/0:0)

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C38H62O6 (614.4546)

DG(13:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/13:0)

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

C38H62O6 (614.4546)

DG(13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/13:0/0:0)

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C38H62O6 (614.4546)

DG(13:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/13:0)

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

C38H62O6 (614.4546)

DG(13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/13:0/0:0)

C38H62O6 (614.4546)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C38H62O6 (614.4546)

DG(13:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/13:0)

C38H62O6 (614.4546)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

C38H62O6 (614.4546)

DG(a-13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/a-13:0/0:0)

C38H62O6 (614.4546)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C38H62O6 (614.4546)

DG(a-13:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/a-13:0)

C38H62O6 (614.4546)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

C38H62O6 (614.4546)

DG(a-13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/a-13:0/0:0)

C38H62O6 (614.4546)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C38H62O6 (614.4546)

DG(a-13:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/a-13:0)

C38H62O6 (614.4546)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

C38H62O6 (614.4546)

DG(a-13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/a-13:0/0:0)

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C38H62O6 (614.4546)

DG(a-13:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/a-13:0)

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

C38H62O6 (614.4546)

DG(a-13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/a-13:0/0:0)

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C38H62O6 (614.4546)

DG(a-13:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/a-13:0)

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

C38H62O6 (614.4546)

DG(a-13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/a-13:0/0:0)

C38H62O6 (614.4546)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C38H62O6 (614.4546)

DG(a-13:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/a-13:0)

C38H62O6 (614.4546)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

C38H62O6 (614.4546)

DG(i-13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/i-13:0/0:0)

C38H62O6 (614.4546)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C38H62O6 (614.4546)

DG(i-13:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/i-13:0)

C38H62O6 (614.4546)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

C38H62O6 (614.4546)

DG(i-13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/i-13:0/0:0)

C38H62O6 (614.4546)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C38H62O6 (614.4546)

DG(i-13:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/i-13:0)

C38H62O6 (614.4546)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

C38H62O6 (614.4546)

DG(i-13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/i-13:0/0:0)

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C38H62O6 (614.4546)

DG(i-13:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/i-13:0)

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

C38H62O6 (614.4546)

DG(i-13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/i-13:0/0:0)

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C38H62O6 (614.4546)

DG(i-13:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/i-13:0)

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

C38H62O6 (614.4546)

DG(i-13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/i-13:0/0:0)

C38H62O6 (614.4546)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C38H62O6 (614.4546)

DG(i-13:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/i-13:0)

C38H62O6 (614.4546)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Iron linoleate

C36H62FeO4 (614.3997)

It is used as a food additive .

(2R,2R,3S,3R)-2,2,3,3-Tetrahydroxy-beta,beta-caroten-4-one

C40H54O5 (614.3971)

Fomitopsic acid

C37H58O7 (614.4182)

19-Hydroxymytiloxanthin

C40H54O5 (614.3971)

Charantoside VII

C36H54O8 (614.3818)

4-Hydroxymytiloxanthin

C40H54O5 (614.3971)

Amarouciaxanthin A

C40H54O5 (614.3971)

D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids Window width to select the precursor ion was 3 Da.; CONE_VOLTAGE was 10 V.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan. Window width to select the precursor ion was 3 Da.; CONE_VOLTAGE was 20 V.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan.

Methylvilangin

C36H54O8 (614.3818)

Arachidonic acid-biotin

C35H58N4O3S (614.4229)

19-O-Methylsiphonaxanthin

C41H58O4 (614.4335)

3beta-hydroxyresiniferonol-6alpha,7alpha-epoxy-9,13,14-ortho-2E-hexadecenoate|synaptolepsis factor K7

C36H54O8 (614.3818)

3beta,16beta,23-triacetoxyolean-12-en-28-oic acid

C36H54O8 (614.3818)

uriolide

C40H54O5 (614.3971)

21-Tigloyl,22-Ac-(3beta,16alpha,21beta,22alpha)-12-Oleanene-3,16,21,22,28-pentol

C37H58O7 (614.4182)

Tri-Ac-(3beta,15alpha,16alpha)-3,15,16-Trihydroxy-12-oleanen-28-oic acid

C36H54O8 (614.3818)

12-hydroxyabieta-8,11,13-trien-7beta-yl 6-hydroxy-7-oxoabieta-5,8,11,13-tetraen-12-yl peroxide|obtusanol B

C40H54O5 (614.3971)

2beta,3beta-Diacetoxy-Delta12-oleanen-23,28-disaeuredimethylester|2beta,3beta-Diacetoxy-olean-12-en-23,28-disaeure-dimethylester|2beta,3beta-diacetoxy-olean-12-ene-23,28-dioic acid dimethyl ester|2beta,3beta-Diacetoxyolean-12-en-23,28-bissaeure-methylester|acide medicagenique diacetate dimethyl ester|diacetate dimethylester de lacide medicagenique|diacetate du methylester de lacide medicanique

C36H54O8 (614.3818)

Di-O-acetyl-acinosolsaeure-dimethylester

C36H54O8 (614.3818)

C36H54O8

C36H54O8 (614.3818)

7alpha-stearyloxy-6beta,12-dihydroxy-abieta-8,12-diene-11,14-dione

C38H62O6 (614.4546)

argentinic acid C methyl ester

C37H58O7 (614.4182)

C40H54O5

C40H54O5 (614.3971)

Giganteumgenin B

C37H58O7 (614.4182)

1,2-dihydro-5beta-hydroxy-21-methyl-6alpha,7alpha-epoxy-9,13,14-ortho-1alpha-(33E-pentadecenoate)-resiniferonol-36-oic acid|kirkinine B

C36H54O8 (614.3818)

21-Tigloyl,28-Ac-(3beta,16alpha,21beta,22alpha)-12-Oleanene-3,16,21,22,28-pentol

C37H58O7 (614.4182)

3beta-[(E)-3-(4-methoxyphenyl)acryloxy]urs-11-en-28,13beta-olide|ehretiolide

C40H54O5 (614.3971)

Antibiotic X 14873H

C34H62O9 (614.4394)

Nemadectin alpha2

C36H54O8 (614.3818)

Phyllactone B

C36H54O8 (614.3818)

C36H62O4Si2

C36H62O4Si2 (614.4186)

2alpha,3beta,23-triacetoxyurs-12-ene-28-oic acid|2alpha,3beta,23alpha-Triacetoxy-urs-12-en-28-oic acid|2alpha.3beta.23-triacetoxy-ursen-(12)-oic acid-(28)|2alpha.3beta.23-Triacetoxy-ursen-(12)-saeure-(28)|asiatic acid triacetate|triacetylasiatic acid

C36H54O8 (614.3818)

Neochrom

C41H58O4 (614.4335)

(25S)-3-O-(2-O-methyl-beta-D-xylopyranosyl)-5alpha-cholestane-3beta,4beta,8,15alpha,16beta,26-hexol|kurilensoside E

C33H58O10 (614.403)

(20R,24S)-24-O-(beta-D-glucopyranosyl)-5alpha-cholestan-3beta,6alpha,8,15beta,24-pentaol|(20R,24S)-24-O-(beta-D-glucopyranosyl)-5alpha-cholestane-3beta,6alpha,8,15beta,4-pentaol|evasterioside D

C33H58O10 (614.403)

C33H58O10

C33H58O10 (614.403)

lincoside L1

C33H58O10 (614.403)

Arg Asn Leu Ala Lys

C26H50N10O7 (614.3864)

Lys Arg Asn Leu Ala

C26H50N10O7 (614.3864)

4,4-dihydroxyadonixanthin

C40H54O5 (614.3971)

Lys Arg Arg Arg

C24H50N14O5 (614.4088)

Gln Arg Arg Arg

C23H46N14O6 (614.3725)

Arg Lys Arg Arg

C24H50N14O5 (614.4088)

Arg Gln Arg Arg

C23H46N14O6 (614.3725)

Arg Arg Lys Arg

C24H50N14O5 (614.4088)

Arg Arg Gln Arg

C23H46N14O6 (614.3725)

Arg Arg Arg Lys

C24H50N14O5 (614.4088)

Arg Arg Arg Gln

C23H46N14O6 (614.3725)

ALLLW

C32H50N6O6 (614.3792)

LIVDR

C27H50N8O8 (614.3751)

QLNLK

C27H50N8O8 (614.3751)

4-Ketonostoxanthin

C40H54O5 (614.3971)

PI(O-20:0/0:0)

C29H59O11P (614.3795)

PA(12:0/18:3(6Z,9Z,12Z))

C33H59O8P (614.3947)

PA(12:0/18:3(9Z,12Z,15Z))

C33H59O8P (614.3947)

PA(18:3(6Z,9Z,12Z)/12:0)

C33H59O8P (614.3947)

PA(18:3(9Z,12Z,15Z)/12:0)

C33H59O8P (614.3947)

Evasterioside D

C33H58O10 (614.403)

Kurilensoside E

C33H58O10 (614.403)

X 14889C

C33H58O10 (614.403)

LPI O-20:0

C29H59O11P (614.3795)

PA 30:3

C33H59O8P (614.3947)

Hellebrigenin-3-(12-hydroxy-laurate)

C36H54O8 (614.3818)

(3R,3R,5S)-3,3,5,19-tetrahydroxy-7,8-didehydro-gamma,epsilon-carotene-8-one

C40H54O5 (614.3971)

19-Methoxy siphonaxanthin

C41H58O4 (614.4335)

PHORBOL, 20-OXO-20-DEOXY 12-MYRISTATE 13-ACETATE, 4BETA

C36H54O8 (614.3818)

1,2-Dimyristoyl-sn-glycero-3-phosphate (sodium salt)

C31H60NaO8P (614.3923)

SLIGKV-NH2

C28H54N8O7 (614.4115)

Protease-Activated Receptor-2, amide (SLIGKV-NH2) is a highly potent protease-activated receptor-2 (PAR2) activating peptide.

2,2-Dihydroxyadonixanthin

C40H54O5 (614.3971)

(6S,3S,5R,6R)-6,3,5-Trihydroxy-4,5,6,7-tetradehydro-7,8,5,6-tetrahydro-beta,beta-carotene-3,8-dione

C40H54O5 (614.3971)

D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

DG(13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

C38H62O6 (614.4546)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/13:0/0:0)

C38H62O6 (614.4546)

DG(13:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C38H62O6 (614.4546)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/13:0)

C38H62O6 (614.4546)

DG(13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

C38H62O6 (614.4546)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/13:0/0:0)

C38H62O6 (614.4546)

DG(13:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C38H62O6 (614.4546)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/13:0)

C38H62O6 (614.4546)

DG(13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/13:0/0:0)

C38H62O6 (614.4546)

DG(13:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/13:0)

C38H62O6 (614.4546)

DG(13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/13:0/0:0)

C38H62O6 (614.4546)

DG(13:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/13:0)

C38H62O6 (614.4546)

DG(13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

C38H62O6 (614.4546)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/13:0/0:0)

C38H62O6 (614.4546)

DG(13:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C38H62O6 (614.4546)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/13:0)

C38H62O6 (614.4546)

DG(a-13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

C38H62O6 (614.4546)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/a-13:0/0:0)

C38H62O6 (614.4546)

DG(a-13:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C38H62O6 (614.4546)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/a-13:0)

C38H62O6 (614.4546)

DG(a-13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

C38H62O6 (614.4546)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/a-13:0/0:0)

C38H62O6 (614.4546)

DG(a-13:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C38H62O6 (614.4546)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/a-13:0)

C38H62O6 (614.4546)

DG(a-13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/a-13:0/0:0)

C38H62O6 (614.4546)

DG(a-13:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/a-13:0)

C38H62O6 (614.4546)

DG(a-13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/a-13:0/0:0)

C38H62O6 (614.4546)

DG(a-13:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/a-13:0)

C38H62O6 (614.4546)

DG(a-13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

C38H62O6 (614.4546)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/a-13:0/0:0)

C38H62O6 (614.4546)

DG(a-13:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C38H62O6 (614.4546)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/a-13:0)

C38H62O6 (614.4546)

DG(i-13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

C38H62O6 (614.4546)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/i-13:0/0:0)

C38H62O6 (614.4546)

DG(i-13:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C38H62O6 (614.4546)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/i-13:0)

C38H62O6 (614.4546)

DG(i-13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

C38H62O6 (614.4546)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/i-13:0/0:0)

C38H62O6 (614.4546)

DG(i-13:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C38H62O6 (614.4546)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/i-13:0)

C38H62O6 (614.4546)

DG(i-13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/i-13:0/0:0)

C38H62O6 (614.4546)

DG(i-13:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/i-13:0)

C38H62O6 (614.4546)

DG(i-13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/i-13:0/0:0)

C38H62O6 (614.4546)

DG(i-13:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/i-13:0)

C38H62O6 (614.4546)

DG(i-13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

C38H62O6 (614.4546)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/i-13:0/0:0)

C38H62O6 (614.4546)

DG(i-13:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C38H62O6 (614.4546)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/i-13:0)

C38H62O6 (614.4546)

NAOrn 10:0/22:5

C37H62N2O5 (614.4658)

NAOrn 16:3/16:2

C37H62N2O5 (614.4658)

NAOrn 20:5/12:0

C37H62N2O5 (614.4658)

NAOrn 22:5/10:0

C37H62N2O5 (614.4658)

NAOrn 16:2/16:3

C37H62N2O5 (614.4658)

NAOrn 18:5/14:0

C37H62N2O5 (614.4658)

NAOrn 18:4/14:1

C37H62N2O5 (614.4658)

NAOrn 16:4/16:1

C37H62N2O5 (614.4658)

Mgdg O-9:0_16:2

C34H62O9 (614.4394)

Mgdg O-21:2_4:0

C34H62O9 (614.4394)

Mgdg O-8:0_17:2

C34H62O9 (614.4394)

Mgdg O-19:2_6:0

C34H62O9 (614.4394)

Mgdg O-16:2_9:0

C34H62O9 (614.4394)

Mgdg O-20:2_5:0

C34H62O9 (614.4394)

Mgdg O-18:2_7:0

C34H62O9 (614.4394)

Mgdg O-17:2_8:0

C34H62O9 (614.4394)

Mgdg O-22:2_3:0

C34H62O9 (614.4394)

PE-Cer 13:2;2O/18:1

C33H63N2O6P (614.4424)

PE-Cer 19:3;2O/12:0

C33H63N2O6P (614.4424)

PE-Cer 16:2;2O/15:1

C33H63N2O6P (614.4424)

PE-Cer 16:3;2O/15:0

C33H63N2O6P (614.4424)

PE-Cer 15:2;2O/16:1

C33H63N2O6P (614.4424)

PE-Cer 14:1;2O/17:2

C33H63N2O6P (614.4424)

PE-Cer 14:3;2O/17:0

C33H63N2O6P (614.4424)

PE-Cer 15:3;2O/16:0

C33H63N2O6P (614.4424)

PE-Cer 12:2;2O/19:1

C33H63N2O6P (614.4424)

PE-Cer 18:2;2O/13:1

C33H63N2O6P (614.4424)

PE-Cer 18:3;2O/13:0

C33H63N2O6P (614.4424)

PE-Cer 14:2;2O/17:1

C33H63N2O6P (614.4424)

PE-Cer 17:2;2O/14:1

C33H63N2O6P (614.4424)

PE-Cer 13:1;2O/18:2

C33H63N2O6P (614.4424)

PE-Cer 17:3;2O/14:0

C33H63N2O6P (614.4424)

PE-Cer 12:1;2O/19:2

C33H63N2O6P (614.4424)

PE-Cer 15:1;2O/16:2

C33H63N2O6P (614.4424)

PE-Cer 15:0;2O/16:3

C33H63N2O6P (614.4424)

PE-Cer 13:0;2O/18:3

C33H63N2O6P (614.4424)

PE-Cer 12:2;2O/18:2;O

C32H59N2O7P (614.406)

PE-Cer 18:3;2O/12:1;O

C32H59N2O7P (614.406)

PE-Cer 14:3;2O/16:1;O

C32H59N2O7P (614.406)

PE-Cer 16:3;2O/14:1;O

C32H59N2O7P (614.406)

PE-Cer 17:3;2O/13:1;O

C32H59N2O7P (614.406)

PE-Cer 14:2;2O/16:2;O

C32H59N2O7P (614.406)

PE-Cer 15:3;2O/15:1;O

C32H59N2O7P (614.406)

[(4E,8E,12E)-2-(heptanoylamino)-3-hydroxyhenicosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(4E,8E,12E)-2-acetamido-3-hydroxyhexacosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(4E,8E,12E)-2-(hexanoylamino)-3-hydroxydocosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(4E,8E,12E)-3-hydroxy-2-(octanoylamino)icosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(4E,8E,12E)-3-hydroxy-2-(nonanoylamino)nonadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(4E,8E,12E)-2-(butanoylamino)-3-hydroxytetracosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)pentacosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(4E,8E,12E)-3-hydroxy-2-(pentanoylamino)tricosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(4E,8E,12E)-2-(decanoylamino)-3-hydroxyoctadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(4E,8E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]trideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxydodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(4E,8E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(4E,8E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(4E,8E,12E)-3-hydroxy-2-(undecanoylamino)heptadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

(2-nonanoyloxy-3-octanoyloxypropyl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C38H62O6 (614.4546)

PEtOH 28:3

C33H59O8P (614.3947)

PMeOH 13:1_16:2

C33H59O8P (614.3947)

PMeOH 13:0_16:3

C33H59O8P (614.3947)

[1-octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C33H58O10 (614.403)

[1-butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C33H58O10 (614.403)

[1-acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C33H58O10 (614.403)

[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C33H58O10 (614.403)

[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C33H58O10 (614.403)

[1-hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C33H58O10 (614.403)

[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C33H58O10 (614.403)

[3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]octyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(4E,8E,12E)-3-hydroxy-2-(tetradecanoylamino)tetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(4E,8E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(4E,8E,12E)-2-(dodecanoylamino)-3-hydroxyhexadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(4E,8E,12E)-3-hydroxy-2-(tridecanoylamino)pentadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

(1-octanoyloxy-3-phosphonooxypropan-2-yl) (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C33H59O8P (614.3947)

[1-phosphonooxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C33H59O8P (614.3947)

(1-decanoyloxy-3-phosphonooxypropan-2-yl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C33H59O8P (614.3947)

[1-phosphonooxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C33H59O8P (614.3947)

(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C33H59O8P (614.3947)

(1-phosphonooxy-3-tetradecanoyloxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C33H59O8P (614.3947)

[(4E,8E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[(4E,8E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyhexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C33H63N2O6P (614.4424)

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C36H56NO7+ (614.4057)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (8E,11E,14E)-icosa-8,11,14-trienoate

C33H59O8P (614.3947)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (6E,9E,12E)-octadeca-6,9,12-trienoate

C33H59O8P (614.3947)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (5E,8E,11E)-icosa-5,8,11-trienoate

C33H59O8P (614.3947)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (8E,11E,14E)-icosa-8,11,14-trienoate

C33H59O8P (614.3947)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C33H59O8P (614.3947)

(1-phosphonooxy-3-tetradecanoyloxypropan-2-yl) (9E,11E,13E)-hexadeca-9,11,13-trienoate

C33H59O8P (614.3947)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C33H59O8P (614.3947)

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C36H56NO7+ (614.4057)

[1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

C33H59O8P (614.3947)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (6E,9E,12E)-octadeca-6,9,12-trienoate

C33H59O8P (614.3947)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (5E,8E,11E)-icosa-5,8,11-trienoate

C33H59O8P (614.3947)

2-[[3-butanoyloxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H57NO8P+ (614.3822)

2-[[3-hexanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H57NO8P+ (614.3822)

2-[[3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoxy]-2-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H61NO7P+ (614.4185)

2-[[3-acetyloxy-2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H57NO8P+ (614.3822)

2-[[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-octanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H57NO8P+ (614.3822)

2-[hydroxy-[3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C33H61NO7P+ (614.4185)

2-[[2-heptanoyloxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H61NO7P+ (614.4185)

2-[[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-nonoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H61NO7P+ (614.4185)

2-[carboxy-[2-[(Z)-tridec-9-enoyl]oxy-3-undecanoyloxypropoxy]methoxy]ethyl-trimethylazanium

C34H64NO8+ (614.4632)

2-[carboxy-[3-decanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]methoxy]ethyl-trimethylazanium

C34H64NO8+ (614.4632)

2-[carboxy-[3-nonanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]methoxy]ethyl-trimethylazanium

C34H64NO8+ (614.4632)

2-[carboxy-[2-[(Z)-hexadec-9-enoyl]oxy-3-octanoyloxypropoxy]methoxy]ethyl-trimethylazanium

C34H64NO8+ (614.4632)

2-[[3-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoxy]-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO6P+ (614.4549)

2-[[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-nonanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H61NO7P+ (614.4185)

Antibiotic X 14889C

C33H58O10 (614.403)

1-eicosyl-glycero-3-phospho-(1-myo-inositol)

C29H59O11P (614.3795)

TG(35:5)

C38H62O6 (614.4546)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

NA-Orn 32:5

C37H62N2O5 (614.4658)

FAHFA 15:4/O-26:7

C41H58O4 (614.4335)

FAHFA 15:5/O-26:6

C41H58O4 (614.4335)

FAHFA 16:4/O-25:7

C41H58O4 (614.4335)

FAHFA 16:5/O-25:6

C41H58O4 (614.4335)

FAHFA 17:4/O-24:7

C41H58O4 (614.4335)

FAHFA 17:5/O-24:6

C41H58O4 (614.4335)

FAHFA 18:4/O-23:7

C41H58O4 (614.4335)

FAHFA 18:5/O-23:6

C41H58O4 (614.4335)

FAHFA 18:6/O-23:5

C41H58O4 (614.4335)

FAHFA 19:4/O-22:7

C41H58O4 (614.4335)

FAHFA 19:5/O-22:6

C41H58O4 (614.4335)

FAHFA 19:6/O-22:5

C41H58O4 (614.4335)

FAHFA 20:4/O-21:7

C41H58O4 (614.4335)

FAHFA 20:5/O-21:6

C41H58O4 (614.4335)

FAHFA 20:6/O-21:5

C41H58O4 (614.4335)

FAHFA 21:5/O-20:6

C41H58O4 (614.4335)

FAHFA 21:6/O-20:5

C41H58O4 (614.4335)

FAHFA 21:7/O-20:4

C41H58O4 (614.4335)

FAHFA 22:5/O-19:6

C41H58O4 (614.4335)

FAHFA 22:6/O-19:5

C41H58O4 (614.4335)

FAHFA 22:7/O-19:4

C41H58O4 (614.4335)

FAHFA 23:5/O-18:6

C41H58O4 (614.4335)

FAHFA 23:6/O-18:5

C41H58O4 (614.4335)

FAHFA 23:7/O-18:4

C41H58O4 (614.4335)

FAHFA 24:6/O-17:5

C41H58O4 (614.4335)

FAHFA 24:7/O-17:4

C41H58O4 (614.4335)

FAHFA 25:6/O-16:5

C41H58O4 (614.4335)

FAHFA 25:7/O-16:4

C41H58O4 (614.4335)

FAHFA 26:6/O-15:5

C41H58O4 (614.4335)

FAHFA 26:7/O-15:4

C41H58O4 (614.4335)

FAHFA 41:11;O

C41H58O4 (614.4335)

MGDG O-24:3;O

C33H58O10 (614.403)

MGDG O-25:2

C34H62O9 (614.4394)

MGMG 25:2

C34H62O9 (614.4394)

MGGA 24:2

C33H58O10 (614.403)

PA O-14:1/17:2

C34H63O7P (614.4311)

PA O-16:2/15:1

C34H63O7P (614.4311)

PA O-30:4;O

C33H59O8P (614.3947)

PA O-31:3

C34H63O7P (614.4311)

PA P-14:0/17:2

C34H63O7P (614.4311)

PA P-14:0/17:2 or PA O-14:1/17:2

C34H63O7P (614.4311)

PA P-16:1/15:1

C34H63O7P (614.4311)

PA P-16:1/15:1 or PA O-16:2/15:1

C34H63O7P (614.4311)

PA P-18:0/12:3;O

C33H59O8P (614.3947)

PA P-31:2

C34H63O7P (614.4311)

PA P-31:2 or PA O-31:3

C34H63O7P (614.4311)

PA 10:0_20:3

C33H59O8P (614.3947)

PA 12:0_18:3

C33H59O8P (614.3947)

PA 26:2/4:1

C33H59O8P (614.3947)

PA 8:0_22:3

C33H59O8P (614.3947)

LPEth 29:3

C34H63O7P (614.4311)

LPM 30:3

C34H63O7P (614.4311)

PEth 28:3

C33H59O8P (614.3947)

PM 29:3

C33H59O8P (614.3947)

CerPE 12:2;O2/18:2;O

C32H59N2O7P (614.406)

CerPE 14:1;O2/17:2

C33H63N2O6P (614.4424)

CerPE 14:2;O2/17:1

C33H63N2O6P (614.4424)

CerPE 15:2;O2/16:1

C33H63N2O6P (614.4424)

CerPE 16:2;O2/15:1

C33H63N2O6P (614.4424)

CerPE 17:2;O2/14:1

C33H63N2O6P (614.4424)

CerPE 31:3;O2

C33H63N2O6P (614.4424)

SM 14:2;O2/14:1

C33H63N2O6P (614.4424)

SM 28:3;O2

C33H63N2O6P (614.4424)

ST 27:0;O5;Hex

C33H58O10 (614.403)

CAE 14:2

C38H62O6 (614.4546)

Palmitoyl Tripeptide-1 (hydrochloride)

C30H55ClN6O5 (614.3922)

Palmitoyl tripeptide-1 hydrochloride is a fatty acid modified polypeptide. Palmitoyl Tripeptide-1 has good wrinkle-removing effect[1].

VKGILS-NH2

C28H54N8O7 (614.4115)

VKGILS-NH2 is a reversed amino acid sequence control peptide for SLIGKV-NH2 (protease-activated receptor 2 (PAR2) agonist). VKGILS-NH2 has no effect on DNA synthesis in cells[1][2].

(4ar,5s,6as,6br,8ar,9r,10s,12ar,12br,14bs)-5,10-bis(acetyloxy)-9-[(acetyloxy)methyl]-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H54O8 (614.3818)

5-(acetyloxy)-6-[3,7-bis(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C36H54O8 (614.3818)

(1r,3r,3as,3bs,5r,5as,6r,7s,9as,9br,11ar)-7-{[(2s,3r,4s,5r)-4,5-dihydroxy-3-methoxyoxan-2-yl]oxy}-1-[(2r,5s)-5-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6-tetrol

C33H58O10 (614.403)

2-{7-[(3-hydroxy-5-methoxy-3-methyl-5-oxopentanoyl)oxy]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-6-methylhept-5-enoic acid

C37H58O7 (614.4182)

2,4a-dimethyl (2s,4ar,6as,6br,8as,10r,11s,12ar,12bs,14bs)-10,11-bis(acetyloxy)-2,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2,4a-dicarboxylate

C36H54O8 (614.3818)

(2r)-2-[(1r,3ar,5ar,7r,9as,11ar)-7-{[(3r)-3-hydroxy-5-methoxy-3-methyl-5-oxopentanoyl]oxy}-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-enoic acid

C37H58O7 (614.4182)

(2e,5s,6s)-6-[(1r,3s,3ar,5ar,7s,9as,11ar)-3,7-bis(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-(acetyloxy)-2-methylhept-2-enoic acid

C36H54O8 (614.3818)

(1s,4s,5s,8r,9r,12r,13s,16s)-5,9,17,17-tetramethyl-8-[(2r,4e)-6-methylhepta-4,6-dien-2-yl]-16-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-19-one

C36H54O8 (614.3818)

(1r,4s,5s,8r,9r,12s,13s,16s)-5,9,17,17-tetramethyl-8-[(2r,4e)-6-methylhepta-4,6-dien-2-yl]-16-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-19-one

C36H54O8 (614.3818)

3beta,16beta,23-triacetoxyolean-12-en-28-oic acid

C36H54O8 (614.3818)

{"Ingredient_id": "HBIN008033","Ingredient_name": "3beta,16beta,23-triacetoxyolean-12-en-28-oic acid","Alias": "3beta,16beta,23-triacetoxyolean-12-en-28-oic acid","Ingredient_formula": "C36H54O8","Ingredient_Smile": "CC(=O)OCC1(C2CCC3(C(C2(CCC1OC(=O)C)C)CC=C4C3(CC(C5(C4CC(CC5)(C)C)C(=O)O)OC(=O)C)C)C)C","Ingredient_weight": "614.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9988;9989;16252","PubChem_id": "11387939","DrugBank_id": "NA"}

7-(2-hydroxypropan-2-yl)-6-(3-methoxy-3-oxopropyl)-3a,6,9a-trimethyl-3-[5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-9-yl 2-hydroxy-3-methylpent-3-enoate

C37H58O7 (614.4182)

7-[(4,5-dihydroxy-3-methoxyoxan-2-yl)oxy]-1-(5-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6-tetrol

C33H58O10 (614.403)

(3r,5s,6s,7s)-3-[(2s,2'r,3'r,4s,5s,5'r)-5'-ethyl-2'-hydroxy-5'-[(1s)-1-hydroxypropyl]-2,3',4-trimethyl-[2,2'-bioxolan]-5-yl]-7-[(2r,3s,4r,5r,6s)-5-ethyl-4,6-dihydroxy-3,6-dimethyloxan-2-yl]-6-hydroxy-5-methyloctan-4-one

C34H62O9 (614.4394)

trimethylsilyl (4as,6as,6br,8ar,9r,10r,12ar,12br,14bs)-9-formyl-2,2,6a,6b,9,12a-hexamethyl-10-[(trimethylsilyl)oxy]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H62O4Si2 (614.4186)

(2r)-2-[(1r,3ar,7r,9as,11ar)-7-[(3-hydroxy-5-methoxy-3-methyl-5-oxopentanoyl)oxy]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-enoic acid

C37H58O7 (614.4182)

(2e,5s,6r)-6-[(1s,3as,4r,5as,7r,9ar,11as)-4,7-bis(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-(acetyloxy)-2-methylhept-2-enoic acid

C36H54O8 (614.3818)

9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-[(2,3,4-trihydroxy-5-methylcyclohexyl)methyl]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C38H62O6 (614.4546)

(3as,7as)-n-(5-carbamimidamido-1-oxopentan-2-yl)-6-hydroxy-1-[(2s)-2-[(1-hydroxyoctylidene)amino]-3-(4-hydroxyphenyl)propanoyl]-octahydroindole-2-carboximidic acid

C32H50N6O6 (614.3792)

4-[(3e,5e,7e,9e,11e,13e,15e)-18-(2,4-dihydroxy-2,6,6-trimethylcyclohexylidene)-3,7,12,16-tetramethyl-2-oxooctadeca-3,5,7,9,11,13,15,17-octaen-1-yl]-4-hydroxy-3,5,5-trimethylcyclohex-2-en-1-one

C40H54O5 (614.3971)

(2s,3as,7as)-n-(5-carbamimidamido-1-oxopentan-2-yl)-6-hydroxy-1-[(2s)-2-[(1-hydroxyoctylidene)amino]-3-(4-hydroxyphenyl)propanoyl]-octahydroindole-2-carboximidic acid

C32H50N6O6 (614.3792)

(5r,6s)-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(4r,5r)-4,5-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-5,6-dihydroxy-2,4,4-trimethylcyclohex-2-en-1-one

C40H54O5 (614.3971)

(4as,9s,10s,10as)-6,10-dihydroxy-7-isopropyl-1,1,4a-trimethyl-5,8-dioxo-2,3,4,9,10,10a-hexahydrophenanthren-9-yl octadecanoate

C38H62O6 (614.4546)

(3r,6s,9r,12r,15s)-3-isopropyl-12-{[4-(methylamino)phenyl]methyl}-6,9,15-tris(2-methylpropyl)-1,4,7,10,13-pentaazacyclopentadeca-1,4,7,10,13-pentaene-2,5,8,11,14-pentol

C33H54N6O5 (614.4155)

3-[(1e,3e,5e,7e,9e)-18-(4,5-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-5,6-dihydroxy-2,4,4-trimethylcyclohex-2-en-1-one

C40H54O5 (614.3971)

(3r,5s,6s,7s)-3-[(2s,2'r,3'r,4s,5'r)-5'-ethyl-2'-hydroxy-5'-[(1s)-1-hydroxypropyl]-2,3',4-trimethyl-[2,2'-bioxolan]-5-yl]-7-[(3s,4r,5r,6s)-5-ethyl-4,6-dihydroxy-3,6-dimethyloxan-2-yl]-6-hydroxy-5-methyloctan-4-one

C34H62O9 (614.4394)

(5s,6r)-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(4r,5r)-4,5-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-5,6-dihydroxy-2,4,4-trimethylcyclohex-2-en-1-one

C40H54O5 (614.3971)

9a,11a-dimethyl-1-(6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl)-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,7-tetrol

C33H58O10 (614.403)

(4s)-4-[(3e,5e,7e,9e,11e,13e,15e)-18-[(2r,4s)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-3,7,12,16-tetramethyl-2-oxooctadeca-3,5,7,9,11,13,15,17-octaen-1-yl]-4-hydroxy-3,5,5-trimethylcyclohex-2-en-1-one

C40H54O5 (614.3971)

(1s,4s,5s,8r,9r,13s,16s)-5,9,17,17-tetramethyl-8-[(2r,4e)-6-methylhepta-4,6-dien-2-yl]-16-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-19-one

C36H54O8 (614.3818)

6,10-dihydroxy-7-isopropyl-1,1,4a-trimethyl-5,8-dioxo-2,3,4,9,10,10a-hexahydrophenanthren-9-yl octadecanoate

C38H62O6 (614.4546)

1,3,4-trihydroxy-5-methoxy-5-oxopentan-2-yl (4e)-13-hydroxy-2,4,6,8-tetramethyl-3-oxotetracos-4-enoate

C34H62O9 (614.4394)

3-isopropyl-12-{[4-(methylamino)phenyl]methyl}-6,9,15-tris(2-methylpropyl)-1,4,7,10,13-pentaazacyclopentadeca-1,4,7,10,13-pentaene-2,5,8,11,14-pentol

C33H54N6O5 (614.4155)

2,4a-dimethyl 10,11-bis(acetyloxy)-2,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2,4a-dicarboxylate

C36H54O8 (614.3818)

7-[(4,5-dihydroxy-3-methoxyoxan-2-yl)oxy]-1-(7-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-2,3,3b,6-tetrol

C33H58O10 (614.403)

(3r,6s,9r,12s,15r)-3-[(4-aminophenyl)methyl]-6,9,12,15-tetrakis(2-methylpropyl)-1,4,7,10,13-pentaazacyclopentadeca-1,4,7,10,13-pentaene-2,5,8,11,14-pentol

C33H54N6O5 (614.4155)

1,3,4-trihydroxy-5-methoxy-5-oxopentan-2-yl 13-hydroxy-2,4,6,8-tetramethyl-3-oxotetracos-4-enoate

C34H62O9 (614.4394)

(4ar)-6-{[(4as,9s,10as)-6-hydroxy-7-isopropyl-1,1,4a-trimethyl-2,3,4,9,10,10a-hexahydrophenanthren-9-yl]peroxy}-10-hydroxy-7-isopropyl-1,1,4a-trimethyl-3,4-dihydro-2h-phenanthren-9-one

C40H54O5 (614.3971)

(1r,9r,11r,15s,19r,22r,27r,28s)-4,9-dihydroxy-6-isopropyl-5-methoxy-12,12,23,23,27-pentamethyloctacyclo[17.11.1.0¹,¹⁷.0²,¹¹.0²,¹⁵.0³,⁸.0¹⁹,²⁸.0²²,²⁷]hentriaconta-3,5,7,16-tetraene-13,18-dione

C40H54O5 (614.3971)

3-[18-(4,5-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-5,6-dihydroxy-2,4,4-trimethylcyclohex-2-en-1-one

C40H54O5 (614.3971)

(3s,3as,5ar,6r,7r,9r,9ar)-7-(2-hydroxypropan-2-yl)-6-(3-methoxy-3-oxopropyl)-3a,6,9a-trimethyl-3-[(3s,5s)-5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-9-yl (2r,3e)-2-hydroxy-3-methylpent-3-enoate

C37H58O7 (614.4182)

2-[1-(2,5-dihydroxy-3,6-dioxo-4-undecylcyclohexa-1,4-dien-1-yl)ethyl]-3,6-dihydroxy-5-undecylcyclohexa-2,5-diene-1,4-dione

C36H54O8 (614.3818)

[(1r,3as,3bs,7r,9s,9ar,9bs,10r,11as)-7,9,10-tris(acetyloxy)-9a-methyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11a-yl]methyl acetate

C36H54O8 (614.3818)

(1r,3r,3as,3bs,5s,5as,7s,9as,9br,11ar)-9a,11a-dimethyl-1-[(2r,5s)-6-methyl-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,7-tetrol

C33H58O10 (614.403)

4-[5-methoxy-1-(2-phenylethenyl)cyclohexa-2,4-dien-1-yl]-2,6,6-trimethyl-3-(2,6,6-trimethyl-3-{2,6,6-trimethylbicyclo[3.1.1]hept-1-en-3-yl}bicyclo[3.1.1]hept-1-en-3-yl)bicyclo[3.1.1]hept-1-ene

C45H58O (614.4487)

3-[(4-aminophenyl)methyl]-6,9,12,15-tetrakis(2-methylpropyl)-1,4,7,10,13-pentaazacyclopentadeca-1,4,7,10,13-pentaene-2,5,8,11,14-pentol

C33H54N6O5 (614.4155)

[7,9,10-tris(acetyloxy)-9a-methyl-1-(6-methyl-5-methylideneheptan-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11a-yl]methyl acetate

C36H54O8 (614.3818)

(1r,2r,3r,3as,3bs,5ar,6r,7s,9as,9br,11ar)-7-{[(2s,3r,4s,5r)-4,5-dihydroxy-3-methoxyoxan-2-yl]oxy}-1-[(2r,6s)-7-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-2,3,3b,6-tetrol

C33H58O10 (614.403)

{3-[16-(acetyloxy)-17-hydroxypentacosyl]-5-hydroxyphenyl}oxidanesulfonic acid

C33H58O8S (614.3852)

5,10-bis(acetyloxy)-9-[(acetyloxy)methyl]-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H54O8 (614.3818)

2-(6-{6-[5'-ethyl-2'-hydroxy-5'-(1-hydroxyethyl)-2,3',4-trimethyl-[2,2'-bioxolan]-5-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl}-3,5-dimethyloxan-2-yl)ethaneperoxoic acid

C33H58O10 (614.403)

(1r,3s,3as,3bs,5r,5as,6r,7s,9as,9br,11ar)-7-{[(2s,3r,4s,5r)-4,5-dihydroxy-3-methoxyoxan-2-yl]oxy}-1-[(2r,5s)-5-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6-tetrol

C33H58O10 (614.403)

trimethylsilyl 9-formyl-2,2,6a,6b,9,12a-hexamethyl-10-[(trimethylsilyl)oxy]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H62O4Si2 (614.4186)

(2z,4e,6e,8e,10e,12e,14e,16z)-3-hydroxy-1-[(1r,4s)-4-hydroxy-1,2,2-trimethylcyclopentyl]-19-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-17-(hydroxymethyl)-4,8,13-trimethylnonadeca-2,4,6,8,10,12,14,16-octaen-18-yn-1-one

C40H54O5 (614.3971)

(1r,3s)-6-[(3e,5e,7e,9e,11e,13e,15z)-17-hydroxy-16-{2-[(1r,4s,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]ethynyl}-3,7,12-trimethylheptadeca-1,3,5,7,9,11,13,15-octaen-1-ylidene]-1,5,5-trimethylcyclohexane-1,3-diol

C40H54O5 (614.3971)